Literature DB >> 15378417

Discrepant views of oncologists and cancer patients on complementary/alternative medicine.

Mary Ann Richardson1, Louise C Mâsse, Kelly Nanny, Christina Sanders.   

Abstract

GOALS: Complementary/ alternative medicine (CAM) is widely used by patients but rarely discussed with oncologists. To understand reasons for the communication gap, this study compares physicians and patients on perceived reasons for CAM use and nondisclosure of use, reactions of physicians to disclosure, and expectations for CAM. PATIENTS AND METHODS: Cross-sectional studies assessed 82 physicians (response 68.3%) and 244 of 374 outpatients (response 65.2%) identified as CAM users at the MD Anderson Cancer Center. Data were summarized by frequency and compared using chi-square tests. MAIN
RESULTS: Physicians were more likely (p<0.001) than patients to attribute CAM use to hope (chi2=17.7), control (chi2=17.5), incurable disease (chi2=42.8), or a nontoxic approach (chi2=50.9). Both physicians and patients agreed CAM could relieve symptoms/side effects, but physicians were less likely (p<0.001) than patients to expect that CAM improved immunity (chi2=72.2) or quality of life (chi2=17.1), cured disease (chi2=42.5), or prolonged life (chi2=58.4). Physicians and patients responded differently (p<0.005) on reasons for nondisclosure. Physicians believed patients felt CAM discussions were unimportant (chi2=7.9) and physicians would not understand (chi2 =48.1), discontinue treatment (chi2=26.4), discourage or disapprove of the use (chi2=131.7); patients attributed nondisclosure to their uncertainty of its benefit (chi2=10.4) and never being asked about CAM (chi2=9.9) by physicians. Physicians were more likely (chi2=9.5, p<0.002) to warn of risks and less likely (chi2=23.5, p<0.001) to encourage use than patients perceived.
CONCLUSION: Oncologists and cancer patients hold discrepant views on CAM that may contribute to a communication gap. Nevertheless, physicians should ask patients about CAM use, discuss possible benefits, and advise of potential risks.

Entities:  

Mesh:

Year:  2004        PMID: 15378417     DOI: 10.1007/s00520-004-0677-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  34 in total

Review 1.  The prevalence and effectiveness of complementary and alternative medicine: what has been learned and what it may be telling us about our patients, ourselves, and conventional medical treatment.

Authors:  M A Moyad
Journal:  Semin Urol Oncol       Date:  2001-11

2.  Use of alternative/complementary therapy in breast cancer patients--a psychological perspective.

Authors:  R Moschèn; G Kemmler; H Schweigkofler; B Holzner; M Dünser; R Richter; W W Fleischhacker; B Sperner-Unterweger
Journal:  Support Care Cancer       Date:  2001-06       Impact factor: 3.603

3.  A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients.

Authors:  V E Von Gruenigen; L J White; M S Kirven; A L Showalter; M P Hopkins; E L Jenison
Journal:  Int J Gynecol Cancer       Date:  2001 May-Jun       Impact factor: 3.437

Review 4.  Free radicals and antioxidants in chemotherapy-induced toxicity.

Authors:  N I Weijl; F J Cleton; S Osanto
Journal:  Cancer Treat Rev       Date:  1997-07       Impact factor: 12.111

5.  Use of alternative medicine by women with early-stage breast cancer.

Authors:  H J Burstein; S Gelber; E Guadagnoli; J C Weeks
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

6.  Use of complementary and alternative medicine in Hawaii cancer patients.

Authors:  C C Gotay; W Hara; B F Issell; G Maskarinec
Journal:  Hawaii Med J       Date:  1999-04

7.  The prevalence of questionable methods of cancer treatment in the United States.

Authors:  I J Lerner; B J Kennedy
Journal:  CA Cancer J Clin       Date:  1992 May-Jun       Impact factor: 508.702

8.  Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology.

Authors:  H Kappauf; D Leykauf-Ammon; U Bruntsch; M Horneber; G Kaiser; G Büschel; W M Gallmeier
Journal:  Support Care Cancer       Date:  2000-07       Impact factor: 3.603

9.  Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement?

Authors:  Nancy L Keating; Edward Guadagnoli; Mary Beth Landrum; Catherine Borbas; Jane C Weeks
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

10.  Shared treatment decision making: what does it mean to physicians?

Authors:  Cathy A Charles; Tim Whelan; Amiram Gafni; Andy Willan; Sylvia Farrell
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

View more
  44 in total

1.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

2.  Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.

Authors:  Michael Frass; Robert Paul Strassl; Helmut Friehs; Michael Müllner; Michael Kundi; Alan D Kaye
Journal:  Ochsner J       Date:  2012

3.  Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.

Authors:  Réme Mountifield; Jane M Andrews; Antonina Mikocka-Walus; Peter Bampton
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

4.  Making lifestyle changes after colorectal cancer: insights for program development.

Authors:  D L Dennis; J L Waring; N Payeur; C Cosby; H M L Daudt
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

Review 5.  Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Authors:  Raquel Gerson-Cwilich; Alberto Serrano-Olvera; Alberto Villalobos-Prieto
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

6.  A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context.

Authors:  Jon Tilburt; Kathleen J Yost; Heinz-Josef Lenz; María Luisa Zúñiga; Thomas O'Byrne; Megan E Branda; Aaron L Leppin; Brittany Kimball; Cara Fernandez; Aminah Jatoi; Amelia Barwise; Ashok Kumbamu; Victor Montori; Barbara A Koenig; Gail Geller; Susan Larson; Debra L Roter
Journal:  Oncologist       Date:  2019-05-17

7.  National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer.

Authors:  Richard T Lee; Andrea Barbo; Gabriel Lopez; Amal Melhem-Bertrandt; Heather Lin; Olufunmilayo I Olopade; Farr A Curlin
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

Review 8.  Effects of complementary and integrative medicine on cancer survivorship.

Authors:  Moshe Frenkel; Victor Sierpina; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2015       Impact factor: 5.075

9.  Disclosure to physicians of CAM use by breast cancer patients: findings from the Women's Healthy Eating and Living Study.

Authors:  Gordon A Saxe; Lisa Madlensky; Sheila Kealey; David P H Wu; Karen L Freeman; John P Pierce
Journal:  Integr Cancer Ther       Date:  2008-09       Impact factor: 3.279

10.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.